Crosscheck

Your medical. Crosschecked.

Metformin

Other names: Glucophage, Fortamet, Glumetza, Glutetza, Riomet

The FAA's guidance for metformin depends on what it is taken for. Each use is below, with its own FAA source and date.

Taken for type 2 diabetes

FAA guidance

Special issuance required.

Wait

14 days

when starting new diabetes therapy (Group B only) or when added to an established treatment regimen

Source: FAA, Acceptable Combinations of Diabetes Medications. FAA date 30 September 2026. Checked by Crosscheck 14 October 2026

The FAA lists metformin in Group B of its diabetes chart, with a 14-day observation when Group B alone is started; the initial certification decision is made by the FAA and the examiner must defer.

Track your medications
Compare FAA documents: metforminWhat each of the three FAA documents says, in plain wordsOpen

Metformin prescribed for weight loss, for prediabetes or for polycystic ovarian syndrome (PCOS) has its own entry.

The FAA's diabetes disposition table says that for diabetes treated with one or more non-insulin diabetic medications the examiner should defer and submit the information to the FAA, and that the initial special issuance requires an FAA decision.

The FAA's AME Assisted Special Issuance page for type II diabetes controlled by medication says that, once the FAA has granted the Authorization, examiners may re-issue a medical certificate under it, provided the applicant does not require insulin, remains on an acceptable oral medication therapy according to the chart of acceptable combinations, and provides the documents it lists. Under medication adjustment, when the dose or formulation is changed or a different drug within the same class is started, the chart lists a 48-hour observation within Groups B to G.

  • 14 days after starting: ground observation

FAA rule for diabetes medication: The FAA makes the initial certification decision and the examiner must defer; combinations of up to three non-insulin medications, only one from each group, are considered acceptable, with an observation period when starting one. Each component in a combination medication is counted separately (for example, rosiglitazone + metformin counts as 2 medications), 4 or more medications may be considered on a case-by-case basis, and for unlisted medications the chart says to consult AMCD or RFS. Under medication adjustment, the chart lists 48 hours within Groups B to G, 7 days within Group A2, 7 days within Group A1 if a new type of insulin is added (with a note that no time is needed for a minor dose change within the same drug class), and 7 days if transitioning between insulin injection to or from a pump, or for new insulin/CGM devices. The FAA's diabetes disposition table says that for diabetes treated with one or more non-insulin diabetic medications the examiner should defer and submit the information to the FAA, and that the initial special issuance requires an FAA decision. The FAA's AME Assisted Special Issuance page for type II diabetes controlled by medication says that, once the FAA has granted the Authorization, examiners may re-issue a medical certificate under it, provided the applicant does not require insulin, remains on an acceptable oral medication therapy according to the chart of acceptable combinations, and provides the documents it lists. For insulin, the chart says to see Medical Certification Using Insulin, and for starting or adding insulin it gives separate lines for third-class pilots or agency ATCS and for first- or second-class pilots, who must use the CGM protocol; insulin has its own entry, which asks for the class of medical. FAA, Acceptable Combinations of Diabetes Medications

Show the FAA's words: metforminThe official FAA wording: four passages, each with its document and dateOpen
FAA, Acceptable Combinations of Diabetes Medications · FAA date 30 September 2026
Initial Certification/Clearance decision is made by the FAA. The AME must defer.
When initiating NEW diabetes therapy (monotherapy or combination medications):
Group B ONLY, 14 days.
B Biguanides: metformin (Glucophage, Fortamet, Glutetza, Riomet)
FAA, Acceptable Combinations of Diabetes Medications · FAA date 30 September 2026
Medication Adjustment
When changing the dose, formulation (e.g., immediate vs. extended release), or switching to a different drug/device within the same class.
Adjusting Medication Observation Time
Within Group B-G 48 hours
FAA, Guide for Aviation Medical Examiners – AASI for Diabetes Mellitus Type II, Medication Controlled · FAA date 28 January 2026
Examiners may re-issue an airman medical certificate under the provisions of an Authorization, provided that the applicant does not require insulin, remains on an acceptable oral medication therapy according to the chart of Acceptable Combinations of Diabetes Medications
FAA, Diabetes Mellitus Disposition Table · FAA date 27 September 2023
B.
Treated with one or more (non-insulin) diabetic medications
DEFER
Submit the information to the FAA.
Initial Special Issuance – Requires FAA Decision
Follow up Special Issuances - See Diabetes Mellitus - Type II, Medication Controlled (Not Insulin)
Sources and dates: metforminThree FAA documents, with the FAA's date and when Crosscheck checked themOpen

Taken for prediabetes

FAA guidance

Acceptable with conditions.

Wait

One week after starting

Different waits apply in other cases.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

Source: FAA, CACI – Prediabetes Worksheet. FAA date 26 August 2026. Checked by Crosscheck 14 October 2026

For prediabetes, the FAA's CACI – Prediabetes Worksheet lists metformin among the medications of which only one is used, and says the examiner should verify a one-week observation after starting the medication and a 48-hour observation with each dose increase, medication or formulation change.

More detail: metforminThe rest of Crosscheck's reading, in plain wordsOpen

Wait

  • 48 hours after each dose increase, medication or formulation change

It says not to use the worksheet if the applicant has ever had an A1C of 6.5% or greater, and that diabetes in remission, diabetes treated with medication, or diabetes insipidus do not qualify. The worksheet applies with all its other criteria.

  • 7 days after starting: ground observation
  • 48 hours after a dose change: ground observation

FAA rule for diabetes medication: The FAA makes the initial certification decision and the examiner must defer; combinations of up to three non-insulin medications, only one from each group, are considered acceptable, with an observation period when starting one. Each component in a combination medication is counted separately (for example, rosiglitazone + metformin counts as 2 medications), 4 or more medications may be considered on a case-by-case basis, and for unlisted medications the chart says to consult AMCD or RFS. Under medication adjustment, the chart lists 48 hours within Groups B to G, 7 days within Group A2, 7 days within Group A1 if a new type of insulin is added (with a note that no time is needed for a minor dose change within the same drug class), and 7 days if transitioning between insulin injection to or from a pump, or for new insulin/CGM devices. The FAA's diabetes disposition table says that for diabetes treated with one or more non-insulin diabetic medications the examiner should defer and submit the information to the FAA, and that the initial special issuance requires an FAA decision. The FAA's AME Assisted Special Issuance page for type II diabetes controlled by medication says that, once the FAA has granted the Authorization, examiners may re-issue a medical certificate under it, provided the applicant does not require insulin, remains on an acceptable oral medication therapy according to the chart of acceptable combinations, and provides the documents it lists. For insulin, the chart says to see Medical Certification Using Insulin, and for starting or adding insulin it gives separate lines for third-class pilots or agency ATCS and for first- or second-class pilots, who must use the CGM protocol; insulin has its own entry, which asks for the class of medical. FAA, Acceptable Combinations of Diabetes Medications

Show the FAA's words: metforminThe official FAA wording: one passage, each with its document and dateOpen
FAA, CACI – Prediabetes Worksheet · FAA date 26 August 2026
If the applicant has EVER had an A1C OF 6.5% OR GREATER, DO NOT USE THIS CACI.
Medication is used for:
Note: Diabetes in remission (diet-controlled), diabetes treated with medication (including insulin), or diabetes insipidus DO NOT qualify for this CACI.
Prediabetes
ONLY ONE of the medications listed is used:
AME should verify one-week observation after starting medication. (See Pharmaceuticals, Weight Loss Medication.) 48-hour observation with each dose increase, medication or formulation change.
Indicate which one medication is used:
metformin OR
Sources and dates: metforminOne FAA document, with the FAA's date and when Crosscheck checked itOpen

Taken for polycystic ovarian syndrome (PCOS)

FAA guidance

Acceptable with conditions.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

FAA label

ACCEPTABLE

Source: FAA, CACI – PCOS Worksheet. FAA date 25 March 2026. Checked by Crosscheck 14 October 2026

For polycystic ovarian syndrome (PCOS), the FAA's CACI worksheet lists metformin among its acceptable medications, which may be used in combination; the others are anti-androgens (for example finasteride and dutasteride), letrozole, oral contraceptives and spironolactone (with a 7-day wait).

More detail: metforminThe rest of Crosscheck's reading, in plain wordsOpen

The worksheet applies with all its other criteria, among them no evidence of diabetes, and the examiner must note in Block 60 one of its statements, which include CACI qualified, and not CACI qualified and deferred.

FAA rule for diabetes medication: The FAA makes the initial certification decision and the examiner must defer; combinations of up to three non-insulin medications, only one from each group, are considered acceptable, with an observation period when starting one. Each component in a combination medication is counted separately (for example, rosiglitazone + metformin counts as 2 medications), 4 or more medications may be considered on a case-by-case basis, and for unlisted medications the chart says to consult AMCD or RFS. Under medication adjustment, the chart lists 48 hours within Groups B to G, 7 days within Group A2, 7 days within Group A1 if a new type of insulin is added (with a note that no time is needed for a minor dose change within the same drug class), and 7 days if transitioning between insulin injection to or from a pump, or for new insulin/CGM devices. The FAA's diabetes disposition table says that for diabetes treated with one or more non-insulin diabetic medications the examiner should defer and submit the information to the FAA, and that the initial special issuance requires an FAA decision. The FAA's AME Assisted Special Issuance page for type II diabetes controlled by medication says that, once the FAA has granted the Authorization, examiners may re-issue a medical certificate under it, provided the applicant does not require insulin, remains on an acceptable oral medication therapy according to the chart of acceptable combinations, and provides the documents it lists. For insulin, the chart says to see Medical Certification Using Insulin, and for starting or adding insulin it gives separate lines for third-class pilots or agency ATCS and for first- or second-class pilots, who must use the CGM protocol; insulin has its own entry, which asks for the class of medical. FAA, Acceptable Combinations of Diabetes Medications

Show the FAA's words: metforminThe official FAA wording: one passage, each with its document and dateOpen
FAA, CACI – PCOS Worksheet · FAA date 25 March 2026
Any evidence of diabetes or prolactinoma?
Treated with the acceptable medication(s) listed:
(May be used in combination)
Indicate which medication(s) used:
anti-androgen (e.g., finasteride, dutasteride)
letrozole
metformin
oral contraceptive
spironolactone (7-day wait)
AME MUST NOTE in Block 60 one of the following:
CACI qualified Polycystic Ovary Syndrome [PCOS].
NOT CACI qualified Polycystic Ovary Syndrome [PCOS]. I have deferred.
Sources and dates: metforminOne FAA document, with the FAA's date and when Crosscheck checked itOpen

Taken for weight loss

metformin for weight loss

FAA guidance

Acceptable with conditions.

Wait

1 week

after starting

Different waits apply in other cases.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

FAA label

ACCEPTABLE

Source: FAA, Weight Loss Medications. FAA date 26 August 2026. Checked by Crosscheck 14 October 2026

When metformin is taken for weight loss as the single diabetic medication component, the FAA lists it as acceptable when A1C is 6.4 or less, there is no diagnosis of diabetes and no history of hypoglycemia requiring intervention, with a one-week observation after starting and a 48-hour observation with each dose increase, medication or formulation change.

Compare FAA documents: metformin for weight lossWhat each of the two FAA documents says, in plain wordsOpen

Wait

  • 48 hours after each dose increase, medication or formulation change

The FAA's CACI – Weight Loss Management worksheet, which the examiner uses for a single diabetic medication taken for weight loss, names it among the medications on which the examiner can issue when the applicant meets all its criteria, and says not to use that CACI if the applicant has ever had an A1C of 6.5% or greater.

  • 7 days after starting: ground observation
  • 48 hours after a dose change: ground observation
Show the FAA's words: metformin for weight lossThe official FAA wording: two passages, each with its document and dateOpen
FAA, Weight Loss Medications · FAA date 26 August 2026
DIABETIC MEDICATIONS USED FOR WEIGHT LOSS: A1C must be 6.4 or less with no diagnosis of diabetes AND No history of hypoglycemia requiring intervention.
ACCEPTABLE Weight Loss Medications When certification criteria are met.
Treated with a single diabetic medication component: metformin, GLP-1 agonist: liraglutide, semaglutide (Wegovy) [injection or oral], tirzepatide (Zepbound) [GIP + GLP-1 Agonist].
One (1) week after starting for weight loss. 48-hour observation with each dose increase, medication, or formulation change.
FAA, CACI – Weight Loss Management Worksheet · FAA date 30 September 2026
If the applicant meets ALL the acceptable certification criteria listed below, the Examiner can issue.
If the applicant has EVER had an A1C OF 6.5% OR GREATER, DO NOT USE THIS CACI.
Sources and dates: metformin for weight lossTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

Taking it for something else? The entries here do not cover that use. The FAA may address it in the guidance for your condition. Ask your examiner.

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.